Human Albumin Improves Long-Term Behavioral Sequelae After Subarachnoid Hemorrhage Through Neurovascular Remodeling

Objective:Subarachnoid hemorrhage results in significant long-lasting neurologic sequelae. Here, we investigated whether human albumin improves long-term outcomes in experimental subarachnoid hemorrhage and whether neurovascular remodeling is involved in the protection of albumin. Design:Laboratory investigation. Setting:Hospital research laboratory. Subjects:Male Sprague-Dawley rats. Interventions:Rats underwent subarachnoid hemorrhage by endovascular perforation. Albumin of either 0.63 or 1.25 g/kg was injected IV immediately after the surgery. Modified Garcia test, beam-walking test, novel object recognition, and Morris water maze were employed to determine the behavioral deficits. The effects of albumin on early neurovascular dysfunction and chronic synaptic plasticity were also studied. Measurements and Main Results:Both doses of albumin significantly improved the sensorimotor scores (F = 31.277; p = 0.001) and cognitive performance (F = 7.982; p = 0.001 in novel object recognition test; and F = 3.431; p = 0.026 in the latency analysis of Morris water maze test) for at least 40 days after subarachnoid hemorrhage. There were remarkable microvasculature hypoperfusion, intracranial pressure rise, early vasoconstriction, neural apoptosis, and degeneration in subarachnoid hemorrhage rats, with albumin significantly attenuating such neurovascular dysfunction. Furthermore, albumin markedly prevented blood-brain barrier disruption, as indicated by less blood-brain barrier leakage, preserved blood-brain barrier–related proteins, and dampened gelatinase activities. The expressions of key synaptic elements were up-regulated with albumin supplementation in both acute and chronic phases. Accordingly, a higher dendritic spine density was observed in the prefrontal and hippocampal areas of albumin-treated subarachnoid hemorrhage animals. Conclusions:Albumin at low-to-moderate doses markedly improves long-term neurobehavioral sequelae after subarachnoid hemorrhage, which may involve an integrated process of neurovascular remodeling.

[1]  J. Suarez,et al.  Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: the ALISAH study. , 2015, Acta neurochirurgica. Supplement.

[2]  Jian-ning Zhang,et al.  Intravenous transfusion of endothelial colony-forming cells attenuates vascular degeneration after cerebral aneurysm induction , 2014, Brain Research.

[3]  Frank Angenstein,et al.  The Actual Intrinsic Excitability of Granular Cells Determines the Ruling Neurovascular Coupling Mechanism in the Rat Dentate Gyrus , 2014, The Journal of Neuroscience.

[4]  D. Brody,et al.  Endovascular Perforation Subarachnoid Hemorrhage Fails to Cause Morris Water Maze Deficits in the Mouse , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  John H. Zhang,et al.  Controversies and evolving new mechanisms in subarachnoid hemorrhage , 2014, Progress in Neurobiology.

[6]  Michael D Hill,et al.  High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial , 2013, The Lancet Neurology.

[7]  Leif Østergaard,et al.  The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  V. Trezza,et al.  Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.

[9]  John H. Zhang,et al.  The importance of early brain injury after subarachnoid hemorrhage , 2012, Progress in Neurobiology.

[10]  R. Macdonald,et al.  The Albumin in Subarachnoid Hemorrhage (ALISAH) Multicenter Pilot Clinical Trial: Safety and Neurologic Outcomes , 2012, Stroke.

[11]  Qianzi Yang,et al.  Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice , 2011, Neuropharmacology.

[12]  L. Xiong,et al.  Age-related differences in experimental stroke: possible involvement of mitochondrial dysfunction and oxidative damage. , 2011, Rejuvenation research.

[13]  L. Xiong,et al.  Ginsenoside Rd in Experimental Stroke: Superior Neuroprotective Efficacy with a Wide Therapeutic Window , 2011, Neurotherapeutics.

[14]  A. Algra,et al.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage , 2011, The Lancet Neurology.

[15]  J. Dreier.  The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease , 2011, Nature Medicine.

[16]  G. Zhao,et al.  Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia , 2011, Neuroscience.

[17]  John H. Zhang,et al.  Recombinant osteopontin in cerebral vasospasm after subarachnoid hemorrhage , 2010, Annals of neurology.

[18]  R. Macdonald,et al.  Learning deficits after experimental subarachnoid hemorrhage in rats , 2010, Neuroscience.

[19]  T. Schweizer,et al.  Cognitive and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage , 2010, Stroke.

[20]  R. Keep,et al.  COMPARISON OF EXPERIMENTAL RAT MODELS OF EARLY BRAIN INJURY AFTER SUBARACHNOID HEMORRHAGE , 2009, Neurosurgery.

[21]  T. Westermaier,et al.  Acute vasoconstriction: decrease and recovery of cerebral blood flow after various intensities of experimental subarachnoid hemorrhage in rats. , 2009, Journal of neurosurgery.

[22]  G. Silasi,et al.  Long-term assessment of motor and cognitive behaviours in the intraluminal perforation model of subarachnoid hemorrhage in rats , 2009, Behavioural Brain Research.

[23]  C. Borel,et al.  Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: New perspectives , 2008, Experimental Neurology.

[24]  A. Cruickshank,et al.  Subarachnoid haemorrhage , 2007, The Lancet.

[25]  Joseph F. Clark,et al.  Bilirubin Oxidation Products (BOXes) and Their Role in Cerebral Vasospasm after Subarachnoid Hemorrhage , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  Rick A Bevins,et al.  Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory' , 2006, Nature Protocols.

[27]  Dean P. Jones,et al.  S-nitroso-albumin carries a thiol-labile pool of nitric oxide, which causes venodilation in the rat. , 2005, American journal of physiology. Heart and circulatory physiology.

[28]  R. Busto,et al.  Albumin Treatment Reduces Neurological Deficit and Protects Blood–Brain Barrier Integrity After Acute Intracortical Hematoma in the Rat , 2005, Stroke.

[29]  Y. Katayama,et al.  Experimental model for investigating hyponatremia after subarachnoid hemorrhage in rats. , 2005, Acta neurochirurgica. Supplement.

[30]  J. Suarez,et al.  Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. , 2004, Journal of neurosurgery.

[31]  T. Mathiesen,et al.  Experimental Subarachnoid Hemorrhage: Cerebral Blood Flow and Brain Metabolism during the Acute Phase in Three Different Models in the Rat , 2004, Neurosurgery.

[32]  M. Moskowitz,et al.  tPA and proteolysis in the neurovascular unit. , 2004, Stroke.

[33]  R. Busto,et al.  Human Albumin Therapy of Acute Ischemic Stroke: Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window , 2001, Stroke.

[34]  R. Busto,et al.  Neuroprotective effect of high-dose albumin therapy against global ischemic brain injury in rats , 1999, Brain Research.

[35]  P. O'Brien,et al.  The effects of heme-binding proteins on the peroxidative and catalatic activities of hemin. , 1999, Free radical biology & medicine.

[36]  M D Ginsberg,et al.  Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. , 1997, Journal of neurosurgery.

[37]  J. Eaton,et al.  Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Asano,et al.  The hemodynamic effects of prolonged albumin administration in beagle dogs exposed to experimental subarachnoid hemorrhage. , 1993, Neurosurgery.